Inventor · disambiguated record
Younong Yu
Also filed as: YU YOUNONG
38 granted patents·19 pending applications·236 citations·filing 2002–2023
97Inventor score
Files withSCHERING CORP17MERCK SHARP & DOHME15INVENTISBIO CO LTD5MERCK SHARP & DOHME LLC3BOYCE CHRISTOPHER W2
Top patents by PatentIndex Score
57 records- 0194US7132445B23,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligandsPHARMACOPEIA DRUG DISCOVERY·Filed 2003·Granted Nov 7, 2006·58 cites·82 claims
- 0294US6740650B2Heterocyclic cytotoxic agentsUNIV RUTGERS·Filed 2002·Granted May 25, 2004·39 cites·32 claims
- 0390US7638531B2Phenoxypiperidines and analogs thereof useful as histamine H3 antagonistsSCHERING CORP·Filed 2006·Granted Dec 29, 2009·19 cites·18 claims
- 0488US8003624B2Functionally selective ALPHA2C adrenoreceptor agonistsSCHERING CORP·Filed 2007·Granted Aug 23, 2011·11 cites·7 claims
- 0588US7964646B23,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligandsSCHERING CORP·Filed 2006·Granted Jun 21, 2011·10 cites·47 claims
- 0688US7947720B23,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligandsSCHERING CORP·Filed 2009·Granted May 24, 2011·10 cites·4 claims
- 0786US10093683B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Oct 9, 2018·4 cites·13 claims
- 0886US9718828B2BTK InhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Aug 1, 2017·7 cites·15 claims
- 0984US7700592B2α2C adrenoreceptor agonistsSCHERING CORP·Filed 2007·Granted Apr 20, 2010·8 cites·11 claims
- 1084US6878709B23,4-di-substituted pyridazinediones as CXC chemokine receptor antagonistsSCHERING CORP·Filed 2003·Granted Apr 12, 2005·20 cites·4 claims
- 1183US10472347B2Aminopyrazine compounds with A2A antagonist propertiesMERCK SHARP & DOHME·Filed 2015·Granted Nov 12, 2019·5 cites·19 claims
- 1283US10246457B2Indazole and azaindazole Btk inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Apr 2, 2019·2 cites·8 claims
- 1381US10011615B2Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with A2A anatagonist propertiesMERCK SHARP & DOHME·Filed 2017·Granted Jul 3, 2018·3 cites·14 claims
- 1479US7960433B2Treatment of chemokine mediated diseasesSCHERING CORP·Filed 2007·Granted Jun 14, 2011·4 cites·11 claims
- 1578US8927559B2Quinazolinone-type compounds as CRTH2 antagonistsASLANIAN ROBERT G·Filed 2011·Granted Jan 6, 2015·6 cites·16 claims
- 1678US7691856B2Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligandsSCHERING CORP·Filed 2007·Granted Apr 6, 2010·3 cites·67 claims
- 1776US8207221B2Crystalline polymorphs of a CXC-chemokine receptor ligandHU MENGWEI·Filed 2008·Granted Jun 26, 2012·2 cites·5 claims
- 1875US10822338B2Substituted aminoquinazoline compounds as A2A antagonistMERCK SHARP & DOHME·Filed 2016·Granted Nov 3, 2020·2 cites·17 claims
- 1975US9499502B25-substituted iminothiazines and their mono- and dioxides as BACE inhibitors, compositions, and their useWU WEN-LIAN·Filed 2012·Granted Nov 22, 2016·3 cites·18 claims
- 2073US9676780B2Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A2A antagonist propertiesMERCK SHARP & DOHME·Filed 2013·Granted Jun 13, 2017·2 cites·15 claims
- 2172US9481682B2Substituted benzamides and substituted pyridinecarboxamides as Btk inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Nov 1, 2016·2 cites·23 claims
- 2272US9469615B2Quinoxalines and AZA-quinoxalines as CRTH2 receptor modulatorsBOYCE CHRISTOPHER W·Filed 2011·Granted Oct 18, 2016·4 cites·27 claims
- 2372US7985748B2ALPHA2C adrenoreceptor agonistsPHARMACOPEIA DRUG DISCOVERY·Filed 2010·Granted Jul 26, 2011·2 cites·15 claims
- 2470US7338968B2Thiadiazoles AS CXC- and CC- chemokine receptor ligandsSCHERING CORP·Filed 2004·Granted Mar 4, 2008·4 cites·46 claims
- 2569US7671212B2Isothiazole dioxides as CXC- and CC-chemokine receptor ligandsSCHERING CORP·Filed 2004·Granted Mar 2, 2010·4 cites·39 claims
- 2668US9422277B2Tricyclic substituted thiadiazine dioxide compounds as BACE inhibitors, compositions and their useMERCK SHARP & DOHME·Filed 2013·Granted Aug 23, 2016·1 cites·13 claims
- 2768US9416129B2Tricyclic substituted thiadiazine dioxide compounds as BACE inhibitors, compositions and their useMERCK SHARP & DOHME·Filed 2013·Granted Aug 16, 2016·1 cites·13 claims
- 2860US2025223301A1Kinase inhibitors, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2023·Application pending·0 cites
- 2960US2025263394A1Compounds, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2023·Application pending·0 cites
- 3057US2024343727A1Pyridazinone or pyridinone compounds, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2022·Application pending·0 cites
- 3156US7786149B2Thiadiazoles as CXC- and CC- chemokine receptor ligandsSCHERING CORP·Filed 2007·Granted Aug 31, 2010·0 cites·19 claims
- 3256US2025195475A1Cdk2 inhibitor and preparation method and use thereofINVENTISBIO CO LTD·Filed 2022·Application pending·0 cites
- 3355US8569312B2Biaryl-spiroaminooxzaoline analogues as alpha 2C adrenergic receptor modulatorsMERCK SHARP & DOHME·Filed 2013·Granted Oct 29, 2013·0 cites·11 claims
- 3455US2025215014A1Kinase inhibitors, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2022·Application pending·0 cites
- 3554US8476274B2Biaryl spiroaminooxazoline analogues as Alpha2C adrenergic receptor modulatorsMERCK SHARP & DOHME·Filed 2012·Granted Jul 2, 2013·0 cites·10 claims
- 3654US2024076297A1Adenosine a2a and a2b receptor dual antagonists for immuno-oncologyMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 3753US12281109B2Inhibitors of histone deacetylase-3 useful for the treatment of cancer, inflammation, neurodegeneration diseases and diabetesMERCK SHARP & DOHME LLC·Filed 2020·Granted Apr 22, 2025·0 cites·13 claims
- 3853US12246008B24-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activity in voltage-gated sodium channelsMERCK SHARP & DOHME LLC·Filed 2019·Granted Mar 11, 2025·0 cites·17 claims
- 3953US2011213029A13,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor LigandsSCHERING CORP·Filed 2011·Application pending·0 cites
- 4053US2023322785A1Adenosine a2a and a2b receptor dual antagonists for immuno-oncologyBOYCE CHRISTOPHER W·Filed 2022·Application pending·0 cites
- 4152US2011190247A1Cyclopropylchromene derivatives as modulators of the alpha-2c receptorSCHERING CORP·Filed 2009·Application pending·0 cites
- 4252US2004106794A13,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligandsSCHERING CORP·Filed 2002·Application pending·0 cites
- 4351US8017642B2Functionally selective ALPHA2C adrenoreceptor agonistsSCHERING CORP·Filed 2008·Granted Sep 13, 2011·0 cites·10 claims
- 4451US2007093477A1Alpha2C adrenoreceptor agonistsSCHERING CORP AND PHARMACOPEIA·Filed 2006·Application pending·0 cites
- 4550US8470863B2Derivatives and analogs of chroman as functionally selective ALPHA2C adrenoreceptor agonistsZHENG JUNYING·Filed 2008·Granted Jun 25, 2013·0 cites·14 claims
- 4650US2005009830A1Heterocyclic cytotoxic agentsUNIV RUTGERS·Filed 2004·Application pending·0 cites
- 4749US2004186142A1Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC- chemokine receptor ligandsSCHERING CORP PHARMACOPEIA INC·Filed 2003·Application pending·0 cites
- 4848US2005192345A1Crystalline polymorphs of a CXC-chemokine receptor ligandSCHERING CORP·Filed 2005·Application pending·0 cites
- 4947US2004053953A1Treatment of chemokine mediated diseasesSCHERING CORP·Filed 2003·Application pending·0 cites
- 5045US9834554B2BTK inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Dec 5, 2017·0 cites·8 claims
Showing the top 50 of 57 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Younong Yu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →